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We have purified and determined the amino acid sequen¢~ of cryptdin-l, a routine Paneth cell defensin, The pcptide corresponds to a previously 
charac~.erized mRNA that accumulates to high abundance during postnatal ontogeny of the small bowel. Acid-extracted intestinal protein was 
fraction.ted by cation-exchange chromatography and fractions were assayed for antimicrobial ctivity. One peak of anti-Salmonella activity 
contai2zed a putative defensin, based on its predicted electrophoretic migration in acid-urea PAGE, The peptide was purified to homogeneity by 
RP-HPLC and sequenced. These studies demonstrate d fensin expression i non.myeloid tissue, The N-terminal e~tension orcryptdin-1 isa unique 
structural feature of this novel epithelial defensin, 
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1. INTRODUCTION 
Many low molecular weight mRNAs accumulate 
during postnatal ontogeny of the mouse small bowel [1], 
including an mRNA predicted to code for a Paneth cell 
defensin [2]. The putative peptide was termed 'cryptdin' 
(crypt defensh0 because of its expression in intestinal 
crypts and its defensin-like structure. Using the cryptdin 
eDNA clone, ash4/134, the developmental regulation 
and high abundance ofcryptdin mRNA were confirmed 
in jejunum and ileum, and the mRNA was localized to 
Paneth cells by in situ hybridization [1,2]. Furthermore, 
the mRNA was shown to be present at low levels in 
5-10% of crypts in 10-day-old mice, at higher levels in 
70-80% of crypts by 16 days of age, and at the adult 
level in every crypt in 20-day-old mice [2], consistent 
with crypt differentiation and coincident with the ap- 
pearance of Paneth cells [3]. Cryptdin mRNA is the first 
defensin-coding sequence found in epithelial cell~. 
All previously characterized det'ensins have been iso- 
lated from phagocytic leukocytes, i.e. neutrophils and 
macrophages [4,5]. Defensins have broad spectrum an- 
timicrobial activities and are characterized bytheir size 
(approx. 4 kDa), cationicity, and six conserved cysteine 
residues arranged in an invariant disulfide bonding pat- 
tern: 1-6, 2--4, 3-5 [6]. The presence of the defensin 
motif in the predicted cryptdin gene product [2], its 
DNA sequence homology with the defensins [7-9], the 
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conserved linkage homology of the cryptdin gene locus 
with the human defensi~ gear(s) on 8p23 [10,11], and 
the existence of defensin resistance genes in the enteric 
pathogen Sahnonella typhimurium [12-14] support he 
hypothesis that cryptdin is an enteric antimicrobial pep- 
tide that may function to restrict microbial colonization 
of the intestinal mucosa. 
To ascertain whether a defensin with the sequence 
predicted by cryptdin eDNA existed in small bowel we 
sought o purify the cryptdin peptide and to determine 
its primary structure. 
2. MATERIALS AND METHODS 
2. I, Mice and preparatiot~ of intestinal extracts 
Outbred Swiss mice [{CrI:CD- I)(ICR)BR], 45-day-old males (30-35 
g) were purchased from Charles River Breeding Laboratories, Inc. 
(North Wilmington, MA). Mice were housed under 12.h cycles oflight 
and darkness and had free access to food and water. 
Jejunum and ileum were removed intact from mice killed by cervical 
dislocation, Intestinal lumens were rinsed with 35 ml PBS, and the 
intestines of individual mice were disrupted in 35 ml of ice.cold 10% 
acetic acid using a Polytron homogenizer (Brinkmann Instruments, 
Westbur~, NY). Homogenates were stirred continuously for 18 h at 
4°C, clarified by centrifugation at27.000 rpm in an SW28, I rotor for 
30 rain at 4°C, dialyzed against 10% acetic acid, lyophilized, and 
stored at -850C. 
2.2. CM-Sepharose chromatography of antlbacterfal intestfncd protefns 
Lyophilized intentinal extract from 12 mi~ was resuspended in 100 
mM ammonium formate (pH 6,2), applied to a 300 ml column of 
CM-Scpharose equilibrated with the .same ammonium formate buffer, 
and washed with 200 ml of ammonium formate buffer. Cationic ~p.  
tides were fractionated with a 2 1 0,10-1.0 M ammonium acetate (pH 
5.2) gradient followed by a 300 mi 2,0 M ammonium a~tate wash [1:5], 
Gradient f;'actions were lyophilized, dissolved in 1.5 ml 0.01% acetic 
146 Published b), Elsevier Science Publishers B, V, 
Volume 304, number 2,3 FEBS LETTERS June 1992 
acid, and tested for antibacterial ctivity against wild-type S. ty- 
phi#)arium (ATCCI0428) and an isogenic phoP mutant of S. ty- 
phlmurium (strain CS015 phoPlO2::TnlOd.Cam [16]) using a well dif- 
fusion assay [I 5l. Wells were created in agaros¢ containing 0.3% tryp- 
tone after seeding with 1 x 10 ~ log-phase cells into which 2/~1 samples 
of reconstituted column fractions were pipetted, and plates were incu- 
bated at 37"C for 14--18 h. Antibacterial ctivity was apparent as clear 
zones around wells containing antibacterial peptides, and the zone 
sizes were concentration-dependent. There was no evidence of an ionic 
strength effect from the column buffer. 
Column fractions containing ant]microbial ctivity were also ana- 
lyzed in acid-urea gels. Samples were lyophilized, dissolved in 30/zl 
of 5% acetic acid containing 3.0 M urea, and electrophorcsed on 12,5% 
acid-urea crylamide gels [17]. 
2.3. l~everse.phase HPLC 
Cr,jptdin-I was purified to homogeneity from active CM-Sepha- 
rose column fractions by reverse-phase HPLC on a 0.46 x 25 cm Vydac 
C-18 column [6]. A cryptdin-l.containing fraction was purified by 
sequential RP-HPLC, first with 0.1% trifluoroacetic a id (TFA) and 
then with 0.13% heptafluorobutyric acid (HFBA). Columns were de- 
veloped using gradients of acetonitrile (1% per rain). 
Cryptdin-I was tentatively identified by comparing its migration 
with authentic rabbit neutrophii defensin NP-1 [18] and with a syn- 
thetic defensin in acid-urea gels. The latter peptide, termed cryptdin-C 
which corresponds to residues 62-94 in the deduced preprocryptdin 
polypeptid¢ sequence [7], was synthesized by solid phase chemistry 
using N-batoxycarbonyi protection [19]. After cleavage/deproteetion 
of synthetic ryptdin-C the reduced peptide was diluted with 30% 
acetic acid and folded by exhaustive dialysis, first against 0.1 M so- 
dium phosphate (pH 8.2), 20 mM guanidine-HCl, 100 mM NaCI, then 
against 5% acetic acid, The peptide was purified by RP-HPLC on a 
1 x 25 cm Vyda¢ C-18 column and mcd subsequently asa reference 
peptide in acid-urea PAGE. 
2.4. Biochemical nalysis 
Amino acid analyses were performed on 6 N HCl hydrolysates 
(150°C, 2 h) of unmodified or performic acid-oxidized peptide. Hy- 
drolysates were derivatized with phenylisothiocyanate, nd the result- 
ing phenyhhiocarbamyl amino acids were quantitated as diner]bed 
previously [l7]. 
Sequence determinations were performed twice by automated 
Edman degradation o  an ABI model 477 system (Applied Biosystems 
Inc., Foster City, CA) with on-line PTH amino acid analysis, Pcptide 
samples were reduced with dithiothraitol and pyridylethylated with 
4-vinylpyridine for sequencing [20]. The carboxyl terminal sequence 
was confirmed by amino acid analysis of a purified tryptic peptide 
derived from the C-terminus. 
3. RESULTS AND DISCUSSION 
3.1. Purification of mouse cryptdin.1 
Cryptdin-I was purified from acid extracts of intact 
mouse jejunum and ileum by a combination of CM- 
Sepharose chromatography and sequential C-18 re. 
verse-phase HPLC. Identification of antibacterial pep- 
tides in column fractions was facilitated by bioassay 
using a defensin-sensitive phoP mutant of $. ty- 
phhnuriurn in combination with analysis on acid-urea 
PAGE. 
Samples of small bowel were homogenized in 10% 
acetic acid, and high-speed supcrnatants of aeid-so!ub!e 
protein were eluted with a 2 1 linear gradient of 0.1-1.0 
M ammonium acetate from a 300 ml CM-Sepharos¢ 
column (data not shown, see [15]). A plate diffusion 
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Fig, 1, Purification of mouse eryptdin-l. A 12.5% aerylamide acid- 
urea gel was loaded with (lane 1) 50 ,uS crude intestinal acid extract. 
(lane 2) 60/zg of CM-Sepharos~ fractions 124--140, (lane 3) i jug 
purified cryptdin-l, (lane 4) i.5/tg synthetic cryptdin C, and (lane 5) 
1/~g rabbit defensin NP-I. The gel was stained with Coomassie blue. 
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Fig. 2. HPLC purification of mouse cryptdin-l. Cryptdin-I was puri- 
fied to homogeneity in this final RP-HPLC step. 75 ,us of a cryptdin- 
containing protein fraction wa~ purified on a C-IS colmmn e.quili- 
brated with 0.13% HFBA (see section 2) and eluted with an acetoni- 
trilo gradient. The peak fraction indicated in the bracket was collected 
and lyophilized. 
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Fig. 3. The primary structure of cryptdin-I. The primary structure of purified cryptdin.l is shown il~ single letter amino acid notation and aligned 
with the dcfensin consensus. Asterisks denote residues that are invariant in 13 of 16 myeloid efeasins; "x' characters in the defensin consensus 
represent residues that vary between defensins. The defensin disulfide bonding pattern is depicted by solid lines connecting cysteines. 
assay [15] of the column fractions was performed using 
wild-type and attenuated strains of S, typhimurium, The 
latter strain, mutated in the phoP locus, had previously 
been shown to be sensitive to defensins [12-14]. Column 
fractions exhibiting reater antibacterial ctivity against 
the phoP mutant than the wild-type Salmonella were 
selected for further purification by HPLC. 
A broad peak of antimicrobial activity, consisting of 
fractions 90-135, elated over the range of 0.55-0.8 M 
ammonium acetate and contained three subpeaks of 
apparent antimicrobial activity. Fractions 124-140 
within this active peak contained peptides characteristic 
of defensins: apparent molecular weights of 4 kDa on 
SDS-PAGE, rapid migration in acid-urea PAGE (>0.6 
x RF of the methyl green tracking dye), and presence of 
an abundant peptide with an RF very similar to that of 
synthetic ryptdin-C in acid-urea PAGE (Fig. 1). Treat- 
ment of the sample with performie acid caused the ap- 
parent cryptdin peptide to disappear from acid-urea 
gels, demonstrating that it contained numerous half- 
cystines (not shown). 
The cryptdin-I peptide was purified from CM-  
Sepharose column fractions 124-140 by RP-HPLC by 
successive chromatographic separations using water- 
acetonitrile lution with 0.1% TFA and 0.13% HFBA 
as ion pairing agents (Fig. 2). The amino acid composi- 
tion of the 4 kDa peptide was completely consistent with 
the composition of cryptdin-C, except that cryptdin-I 
contained three additional amino acids: leucine, argin- 
ine and aspartic acid. 
3.2. The primary structure of  mouse cryptdin 
A sample of  the purified peptide was reduced, S- 
pyridylethylated, and subjected to two gas-phase se- 
quencing determinations (Fig. 3). The carboxyl terminal 
sequence was confirmed by amino acid analysis of the 
tryptie peptide consisting of  residues 26--35. These de- 
terminations confirmed the amino acid analysis and the 
sequence predicted by the cryptdin eDNA sequence [2]. 
However, the data show that the N-terminus of 
cryptdin-I is extended in relation to other defensins. 
Although known leukocyte-derived defensins contain a 
maximum of two residues prior to the first eysteine, the 
first cysteine in cryptdin-I is prcced~d by five amino 
acids. Cryptdin-C, which migrates lightly faster than 
cryptdin-1 in acid-urea PAGE, was synthesized with 
the expectation that the N-terminus ofcryptdin- 1would 
be structurally similar to that of  the myeloid defcnsins, 
Although the significance of the pentapeptidyl N-termi- 
nal sequence is not known, the relative R /s  ofcryptdin- 
1 and synthetic ryptdin-C are consistent with the differ- 
ence in their primary structures. 
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